Drawing for DXCOVER

USPTO serial 79299097

DXCOVER

Reviewed by CopyMark Law Group

Reg. 6481155Status 700Renewal
Filing date
Status date
Registration date
Sep 14, 2021
Examiner
FOSTER, ALEXANDRA M.
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with DXCOVER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
009Scientific apparatus and instruments for analysing biofluids and detecting diseases; laboratory apparatus and instruments for microscopy; scientific apparatus, namely, spectrometers and parts and fittings therefor; spectroscopes; scientific apparatus, namely, spectrophotometers for measuring the infrared spectrum of biofluids for the purpose of detecting diseases; spectrometry apparatus; spectrograph apparatus; data processing equipment, namely, couplers; downloadable computer software for use in medical and clinical analysis and disease diagnostics for analyzing medical data to assist in providing clinical interpretations; computer hardware; downloadable electronic publications in the nature of newsletters, reports and brochures in the field of science and medicine; data processing apparatus with artificial intelligence; downloadable artificial intelligence and machine learning software for analyzing medical data to assist in providing clinical interpretations in the field of medical and clinical analysis and disease diagnostics; research laboratory analysers for measuring, testing and analysing blood and other bodily fluids; parts and fittings for all the aforesaid goods; all of the aforesaid goods relating to spectroscopic analysisACTIVE
010Medical apparatus and instruments for analysing biofluids and detecting diseases; diagnostic apparatus for medical purposes, namely, analysing biofluids and detecting diseases; medical apparatus for the treatment of cancer; blood testing apparatus; medical diagnostics instruments and apparatus for the analysis of bodily fluids; medical apparatus, instruments and devices for liquid biopsy analysis; parts and fittings for all the aforesaid goods; all of the aforesaid goods relating to spectroscopic analysisACTIVE
042Scientific and technological services, namely, research, design, analysis and testing in the field of medical and clinical analysis and disease diagnostics; industrial analysis and research services in the field of medical and clinical analysis and disease diagnostics; design and development of computer hardware and software; design and development of computer software for use with medical technology; engineering services and design services for scientific equipment and apparatus for microscopy, spectroscopy and scientific imaging; medical research services; clinical research in the field of biofluid analysis and disease detection; medical laboratory services; computer programming in the medical field; design and development of medical technology; design and development of medical diagnostic apparatus; blood analysis services; scientific research for medical purposes in the area of cancerous diseases; research in the field of artificial intelligence; providing on-line non-downloadable software using artificial intelligence for analyzing medical data to assist in providing clinical interpretations in the field of medical and clinical analysis and disease diagnostics; software as a service (SaaS) services featuring software using artificial intelligence for analyzing medical data to assist in providing clinical interpretations in the field of medical and clinical analysis and disease diagnostics; software as a service (SaaS) services featuring software for analyzing medical data to assist in providing clinical interpretations in the field of medical and clinical analysis and disease diagnostics; analysis and evaluation of technical data, namely, scientific and medical data for analyzing medical data to assist in providing clinical interpretations in the field of medical and clinical analysis and disease diagnostics; technical support services, namely, computerised analysis of technical data; scientific and technological services, namely, overseeing, monitoring and managing scientific and medical experiments and tests in the field of medical and clinical analysis and disease diagnostics; scientific and technological services, namely, overseeing, monitoring and managing the analysis and evaluation of scientific and medical data in the field of medical and clinical analysis and disease diagnostics; design of scientific experiments; provision of scientific reports relating to scientific research in the field of medical and clinical analysis and disease diagnostics; advice, information and consultancy services for all of the aforesaid services; all of the aforesaid services relating to spectroscopic analysisACTIVE
044Medical services; medical care services; health clinic services; healthcare services, namely, medical analysis services for diagnostic and treatment purposes; medical diagnostic testing, monitoring, and reporting services; providing cancer screening services; preparation of medical reports relating to health care matters in the field of biofluid analysis and the detection of diseases for medical professionals and patients; medical testing for diagnostic or treatment purposes; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical analysis services for the diagnosis of cancer; medical testing of blood; medical testing in the nature of liquid biopsy testing for medical purposes; advice, information and consultancy services for all of the aforesaid services; all of the aforesaid services relating to spectroscopic analysisACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 21, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Mar 1, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB
Mar 1, 2022FIMPFINAL DISPOSITION PROCESSED
Dec 14, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 14, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 11, 2021ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Jul 2, 2021ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB
Jul 1, 2021ETOFEXTENSION OF TIME TO OPPOSE RECEIVED
Jun 1, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 1, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 15, 2021ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB
May 12, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 26, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Apr 26, 2021XAECEXAMINER'S AMENDMENT ENTERED
Apr 26, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 26, 2021GNEAEXAMINERS AMENDMENT E-MAILED
Apr 26, 2021CNEAEXAMINERS AMENDMENT -WRITTEN
Apr 24, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Apr 23, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 23, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 22, 2021RFNTREFUSAL PROCESSED BY IB
Mar 4, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 4, 2021RFRRREFUSAL PROCESSED BY MPU
Feb 22, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 21, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 17, 2021DOCKASSIGNED TO EXAMINER
Dec 8, 2020MAFRAPPLICATION FILING RECEIPT MAILED
Dec 4, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 3, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance